{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:21:41Z","timestamp":1787851301800,"version":"build-2784847793"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008061","name":"Mutua Madrile\u00f1a Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.esmoop.2026.108342","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:15:29Z","timestamp":1785341729000},"page":"108342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-0982","authenticated-orcid":false,"given":"G.","family":"Serna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-3513","authenticated-orcid":false,"given":"M.","family":"Ob\u00f3n-Santacana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Baraibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-5713","authenticated-orcid":false,"given":"F.","family":"Moratalla-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-0170","authenticated-orcid":false,"given":"F.","family":"Ruiz-Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Guin\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-4671","authenticated-orcid":false,"given":"M.","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1059-635X","authenticated-orcid":false,"given":"S.","family":"Landolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-5830","authenticated-orcid":false,"given":"A.","family":"Fern\u00e1ndez Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Lopez Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-0110","authenticated-orcid":false,"given":"M.","family":"Cuatrecasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-2959","authenticated-orcid":false,"given":"S.","family":"Lopez-Prades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-4998","authenticated-orcid":false,"given":"I.","family":"Gardeazabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-741X","authenticated-orcid":false,"given":"C.","family":"L\u00f3pez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7564-0334","authenticated-orcid":false,"given":"M.L.","family":"Cagigal Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gonz\u00e1lez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-2028","authenticated-orcid":false,"given":"J.L.","family":"Lopez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garc\u00eda Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-4130","authenticated-orcid":false,"given":"S.","family":"Rosell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4888-1655","authenticated-orcid":false,"given":"N.","family":"Tarazona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Comas Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bambaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Arregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Colldeforns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bay\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-8139","authenticated-orcid":false,"given":"J.","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4653-6324","authenticated-orcid":false,"given":"E.","family":"\u00c9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-5487","authenticated-orcid":false,"given":"V.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-0990","authenticated-orcid":false,"given":"P.","family":"Nuciforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2026.108342_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2026.108342_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","article-title":"Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib3","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III colon cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2020.07.031","article-title":"A new prognostic and predictive tool for shared decision making in stage III colon cancer","volume":"138","author":"Sobrero","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2026.108342_bib6","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2004.09.059","article-title":"Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?","volume":"22","author":"Gill","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib7","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1200\/JCO.2011.37.8646","article-title":"Path toward prognostication and prediction: an evolving matrix","volume":"29","author":"Benson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib8","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","article-title":"Adjuvant chemotherapy for stage II colon cancer with poor prognostic features","volume":"29","author":"O\u2019Connor","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.24.00648","article-title":"Combined analyses of circulating tumor DNA and Immunoscore in patients with stage III colon cancer: a post hoc analysis of the PRODIGE-GERCOR IDEA-France\/HORG-IDEA-Greece trials","volume":"43","author":"Taieb","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaoncol.2025.5144","article-title":"Predictive role of circulating tumor DNA in stage III colon cancer treated with celecoxib: a post hoc analysis of the CALGB (Alliance)\/SWOG 80702 phase 3 randomized clinical trial","volume":"12","author":"Zhang","year":"2026","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1200\/JCO-25-02086","article-title":"Tissue-free circulating tumor DNA assay and patient outcome in a phase III trial of FOLFOX-based adjuvant chemotherapy (Alliance N0147)","volume":"44","author":"Sinicrope","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.annonc.2024.08.2240","article-title":"Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY","volume":"35","author":"Kataoka","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006887","article-title":"Real-world monitoring of ctDNA reliably predicts cancer recurrence and treatment efficacy in patients with resected stages I-III colon cancer","author":"Cohen","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.esmoop.2026.108342_bib14","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1001\/jama.2025.2191","article-title":"The microbiome and cancer: a translational science review","volume":"333","author":"Fernandez","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.esmoop.2026.108342_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.gastro.2022.10.018","article-title":"Gut microbiota modulation of efficacy and toxicity of cancer chemotherapy and immunotherapy","volume":"164","author":"Chrysostomou","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.esmoop.2026.108342_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.esmoop.2026.108342_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","article-title":"Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer","volume":"25","author":"Yachida","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","article-title":"Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer","volume":"358","author":"Bullman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.esmoop.2026.108342_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/gr.126516.111","article-title":"Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma","volume":"22","author":"Castellarin","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.esmoop.2026.108342_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1101\/gr.126573.111","article-title":"Genomic analysis identifies association of Fusobacterium with colorectal carcinoma","volume":"22","author":"Kostic","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.esmoop.2026.108342_bib21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.esmoop.2026.108342_bib22","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-20-3807","article-title":"Microbiome analysis of more than 2,000 NHS Bowel Cancer Screening Programme samples shows the potential to improve screening accuracy","volume":"27","author":"Young","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108342_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","article-title":"Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer","volume":"25","author":"Wirbel","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib24","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","article-title":"Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis","volume":"65","author":"Mima","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.esmoop.2026.108342_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.esmoop.2026.108342_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","article-title":"Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to NF-\u03baB and upregulating microRNA-21","volume":"152","author":"Yang","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.esmoop.2026.108342_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.esmoop.2026.108342_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.esmoop.2026.108342_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2024.04.226","article-title":"Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin\/\u03b2-catenin\/GPX4 axis in colorectal cancer","volume":"220","author":"Li","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1186\/s12967-025-07226-3","article-title":"Fusobacterium nucleatum enhances oxaliplatin resistance in colon cancer by increasing PVT1 expression","volume":"23","author":"Gao","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chom.2024.07.008","article-title":"Navigating beyond associations: opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis","volume":"32","author":"Baas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.esmoop.2026.108342_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.esmoop.2026.108342_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.esmoop.2026.108342_bib34","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.annonc.2020.06.003","article-title":"Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer","volume":"31","author":"Serna","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41698-021-00163-6","article-title":"Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer","volume":"5","author":"Griguolo","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib36","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.esmoop.2026.108342_bib37","author":"Therneau"},{"key":"10.1016\/j.esmoop.2026.108342_bib38","author":"Kassambara"},{"key":"10.1016\/j.esmoop.2026.108342_bib39","doi-asserted-by":"crossref","first-page":"46158","DOI":"10.18632\/oncotarget.10064","article-title":"Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients\u2019 survival? A pilot study on relevant mechanism","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.esmoop.2026.108342_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.21037\/tcr.2016.10.45","article-title":"Fusobacterium nucleatum infection is correlated with tumor metastasis and postoperative survival of colorectal cancer patients in China","volume":"5","author":"Sun","year":"2016","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108342_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00535-017-1382-6","article-title":"Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population","volume":"53","author":"Yamaoka","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.esmoop.2026.108342_bib42","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s10096-014-2081-3","article-title":"Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome","volume":"33","author":"Flanagan","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.esmoop.2026.108342_bib43","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ijc.29488","article-title":"Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway","volume":"137","author":"Ito","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.esmoop.2026.108342_bib44","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1158\/0008-5472.CAN-13-1865","article-title":"Fusobacterium in colonic flora and molecular features of colorectal carcinoma","volume":"74","author":"Tahara","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108342_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4132\/jptm.2022.03.13","article-title":"Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systematic review and meta-analysis","volume":"56","author":"Kim","year":"2022","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.esmoop.2026.108342_bib46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3389\/fonc.2019.00813","article-title":"Microbiota profile and impact of Fusobacterium nucleatum in colorectal cancer patients of Barretos Cancer Hospital","volume":"9","author":"de Carvalho","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib47","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3390\/cancers13215421","article-title":"Performance of 16S metagenomic profiling in formalin-fixed paraffin-embedded versus fresh-frozen colorectal cancer tissues","volume":"13","author":"Borgognone","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2026.108342_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41579-018-0129-6","article-title":"Fusobacterium nucleatum\u2014symbiont, opportunist and oncobacterium","volume":"17","author":"Brennan","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.esmoop.2026.108342_bib49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2468-1253(20)30362-9","article-title":"The relationship between gastrointestinal cancers and the microbiota","volume":"6","author":"LaCourse","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.esmoop.2026.108342_bib50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2049-2618-1-16","article-title":"Co-occurrence of anaerobic bacteria in colorectal carcinomas","volume":"1","author":"Warren","year":"2013","journal-title":"Microbiome"},{"key":"10.1016\/j.esmoop.2026.108342_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11237-6","article-title":"Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer","volume":"7","author":"Purcell","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.esmoop.2026.108342_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.chom.2020.12.001","article-title":"The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants","volume":"29","author":"Dohlman","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.esmoop.2026.108342_bib53","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.3390\/cancers14174214","article-title":"Meta-analysis and validation of a colorectal cancer risk prediction model using deep sequenced fecal metagenomes","volume":"14","author":"Ob\u00f3n-Santacana","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2026.108342_bib54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jamaoncol.2015.1377","article-title":"Fusobacterium nucleatum and T cells in colorectal carcinoma","volume":"1","author":"Mima","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2026.108342_bib55","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1158\/2326-6066.CIR-18-0174","article-title":"Fusobacterium nucleatum in colorectal cancer relates to immune response differentially by tumor microsatellite instability status","volume":"6","author":"Hamada","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.esmoop.2026.108342_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.esmoop.2026.108342_bib57","doi-asserted-by":"crossref","first-page":"8626","DOI":"10.3748\/wjg.v23.i48.8626","article-title":"Fusobacterium\u2019s link to colorectal neoplasia sequenced: a systematic review and future insights","volume":"23","author":"Hussan","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.esmoop.2026.108342_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/1055-9965.EPI-18-1295","article-title":"Fusobacterium nucleatum in the colorectum and its association with cancer risk and survival: a systematic review and meta-analysis","volume":"29","author":"Gethings-Behncke","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.esmoop.2026.108342_bib59","first-page":"1227","article-title":"Intratumoral bacteria, 5-fluorouracil metabolism, and chemoresistance in colorectal cancer","volume":"377","author":"LaCourse","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.esmoop.2026.108342_bib60","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cam4.1850","article-title":"Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2019","journal-title":"Cancer Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:33:34Z","timestamp":1787848414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926022842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2059702926022842"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108342","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108342"}}